Mammoth Biosciences

Mammoth Biosciences is a biotechnology company based in Brisbane, California. The company employs 38 people and has generated $50 million in revenue. Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna, alongside Trevor Martin, Janice Chen, and Lucas Harrington, Mammoth Biosciences is dedicated to developing innovative gene editing technologies. Mammoth Biosciences specializes in leveraging its proprietary ultracompact CRISPR systems to create long-term curative therapies. Their technology also has applications in decentralized precision diagnostics. The company's ultracompact proteins are designed to facilitate in vivo gene editing in hard-to-reach tissues, utilizing various techniques including nuclease applications, base editing, gene writing, and epigenetic editing. Mammoth Biosciences is committed to expanding its pipeline of potential in vivo gene editing therapeutics and capabilities. The company collaborates with prominent pharmaceutical and biotechnology companies to further the reach of its innovative and proprietary technology. Mammoth Biosciences can be found online at mammoth.bio.